FuturHealth Tirzepatide Cost: What the Evidence Shows (and Doesn't)

Last reviewed: September 11, 2026 Last updated: September 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

FuturHealth charges a documented $129.99/month membership fee (captured September 4, 2026; landing.fh.co/terms), but the company does not publicly disclose tirzepatide medication pricing. Intake verification was blocked at the results gate before reaching checkout, so no tirzepatide line-item cost, dose-specific pricing table, or final invoice was accessible. FuturHealth lists Zepbound (branded tirzepatide) among offered products and advertises medication "from $229" for semaglutide, but whether tirzepatide medication carries the same floor, a different rate, or variable dose pricing cannot be confirmed from available evidence. Additional labs and other charges may apply. For comparison, PlexusDx tirzepatide injection runs $289/month month-to-month with no membership fee, same price at every dose, and no separate labs or visit charges.

FuturHealth cost structure: what the evidence documents

The $129.99 monthly membership is charged separately from medication costs. FuturHealth's terms (landing.fh.co/terms, captured September 4, 2026) confirm this recurring fee; the advertised "from $229" figure appears alongside the membership language and is described as medication cost for semaglutide. Verification attempted to reach checkout pricing through the intake questionnaire, but the process cleared email and phone fields and left the "View results" button disabled, blocking access to an account dashboard or invoice (captured September 4, 2026).

FuturHealth lists Wegovy injection, Wegovy pill, Zepbound, Ozempic, and Foundayo pill among offered products (captured September 4, 2026), confirming tirzepatide availability under the Zepbound brand name, but no tirzepatide-specific medication price was published or reached during verification.

Estimating total cost without tirzepatide medication pricing

Because FuturHealth's tirzepatide medication cost is undisclosed, a full 12-month calculation cannot be completed with confidence. Using the documented semaglutide floor as a reference point:

FuturHealth semaglutide floor estimate (month-to-month, our calculation)

• Membership: $129.99/month × 12 = $1,559.88
• Medication (floor): $229/month × 12 = $2,748
• Total 12-month (minimum): $4,307.88
• Effective per month: $358.99

Caveat: This calculation applies the lowest advertised semaglutide rate. Actual tirzepatide medication cost is unknown and typically exceeds semaglutide pricing across telehealth platforms. Labs and other fees may apply but are not quantified in available sources. Confirm all charges at checkout.

PlexusDx tirzepatide injection (month-to-month)

• $289/month × 12 = $3,468
• Effective per month: $289
• No membership fee, no labs charges, same price at every dose.

PlexusDx tirzepatide injection (6-month prepaid plan)

• $249/month × 6 = $1,494 upfront, twice per year
• Total 12-month: $2,988
• Effective per month (prepaid equivalent): $249
• Labeled as prepaid; requires $1,494 commitment every six months.

Even using FuturHealth's semaglutide floor, the membership-plus-medication model yields an estimated $358.99 per month before labs or other fees. PlexusDx tirzepatide month-to-month runs $289 all-in, and the 6-month prepaid plan brings the effective rate to $249 per month. The true FuturHealth tirzepatide cost will depend on undisclosed medication pricing and any additional charges assessed during care.

Decision factors when medication pricing is unavailable

Pricing transparency

PlexusDx publishes tirzepatide injection pricing on the product page before intake: $289 month-to-month, $269 per month on a 3-month plan, $249 per month on a 6-month plan. Every dose tier carries the same rate. FuturHealth's tirzepatide medication cost is not published and was not accessible through verification; the intake process blocked progression to an account or checkout view (captured September 4, 2026). Readers who prioritize knowing total cost before starting intake will find documented figures at PlexusDx and an evidence gap at FuturHealth.

Fee structure complexity

FuturHealth separates membership ($129.99/month) from medication cost, and terms note that labs and other charges may apply (landing.fh.co/terms, captured September 4, 2026). This multi-component billing increases the risk of surprise charges and makes month-to-month budgeting dependent on variable line items. PlexusDx uses a single monthly price covering provider visit, prescription review, medication, and shipping—no membership, no separate labs invoices, no hidden fees. For readers managing fixed budgets or employer reimbursement that requires itemized predictability, the all-inclusive model removes guesswork.

Dose-tier pricing and escalation risk

No evidence shows whether FuturHealth charges the same medication rate across tirzepatide maintenance doses (5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) or applies dose-tier pricing that raises cost as titration progresses. PlexusDx holds medication cost constant: a patient on 15 mg tirzepatide pays the same $289/month as a patient starting at 2.5 mg. Dose-tier models can double or triple medication expense over the course of treatment; the absence of a published FuturHealth dose table leaves that risk unquantified.

Brand-name access

FuturHealth lists Zepbound—the FDA-approved brand-name tirzepatide—among available products (captured September 4, 2026). For patients who prefer or require branded drugs over compounded formulations, FuturHealth offers that option. PlexusDx works exclusively with compounded tirzepatide through licensed 503A pharmacies. Compounded medications are not FDA-approved; the FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient, and insurance coverage typically does not extend to compounded GLP-1s. Readers prioritizing brand-name status should confirm current FuturHealth inventory and cost at intake, as branded shortages have historically shifted telehealth offerings to compounded alternatives.

Choose FuturHealth if…

• You require access to Zepbound or other FDA-approved brand-name tirzepatide and are willing to navigate undisclosed medication pricing to secure it.
• You are comfortable with a multi-component fee structure (membership, medication, potential labs) and plan to confirm final cost during intake before committing.
• You prefer a platform that offers both GLP-1 injection and pill formulations under one membership, even when per-medication pricing is not published in advance.

Choose PlexusDx if…

• You want tirzepatide medication pricing published and locked before you start intake—$289/month month-to-month, $269/month prepaid over three months, $249/month prepaid over six months.
• You prefer an all-inclusive monthly rate with no membership fee, no separate labs charges, and no dose-tier price increases as you titrate.
• You value decision-grade cost transparency and are comfortable with compounded tirzepatide dispensed by a licensed 503A pharmacy under clinician supervision.

Methodology and freshness

This analysis reflects evidence captured September 4–9, 2026. FuturHealth's $129.99/month membership fee and "from $229" semaglutide medication floor were documented from the company's website and terms page (landing.fh.co/terms). Intake verification attempted to reach tirzepatide checkout pricing but was blocked when the results-gate form cleared contact fields without enabling account access. No tirzepatide medication cost, dose table, or final invoice was accessible. All 12-month calculations are ours, derived from documented month-to-month fees; the FuturHealth estimate applies only the semaglutide floor and is labeled as a minimum. PlexusDx pricing reflects the standing product-page rates as of September 11, 2026. Readers should confirm FuturHealth's current tirzepatide medication cost, dose pricing, and labs fees at intake, as these figures were not available in the verification window. The PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star or higher) was captured September 9, 2026 from trustpilot.com/review/plexusdx.com.

Frequently Asked Questions

Does FuturHealth publish tirzepatide medication pricing before intake?

No. FuturHealth's website lists Zepbound among offered products and advertises medication "from $229," but that figure appears tied to semaglutide. Tirzepatide-specific costs were not published and intake verification was blocked before reaching checkout (captured September 4, 2026). Confirm tirzepatide pricing during your intake or by contacting FuturHealth directly.

What is FuturHealth's total monthly cost for tirzepatide?

The documented membership fee is $129.99/month, but tirzepatide medication cost is undisclosed, and labs or other charges may apply. Without the medication line-item, a reliable total cannot be calculated. Using the semaglutide floor yields a minimum estimated $358.99/month before any additional fees; actual tirzepatide cost will likely be higher.

Does PlexusDx charge a membership fee for tirzepatide?

No. PlexusDx tirzepatide injection is $289/month month-to-month, $269/month on a 3-month plan, or $249/month on a 6-month plan, all-inclusive. There is no separate membership, no labs fee, and no visit charge. The published price covers provider consultation, prescription, medication, and shipping.

Does tirzepatide cost more at higher doses?

At PlexusDx, no—every tirzepatide dose (2.5 mg through 15 mg) carries the same monthly price. FuturHealth's dose-tier pricing model is unknown because no tirzepatide medication table was published or accessible. Confirm whether FuturHealth applies dose-based pricing during intake to avoid surprise increases as you titrate.

Can I get brand-name Zepbound through PlexusDx?

No. PlexusDx works with licensed 503A compounding pharmacies and dispenses compounded tirzepatide, which is not FDA-approved. FuturHealth lists Zepbound among available products, but confirm current inventory and cost at intake, as branded availability depends on manufacturer supply and is subject to change.

Sources

• PlexusDx pricing and policy documentation (plexusdx.com; accessed July 17–23, 2026; September 11, 2026)
• FuturHealth website and terms page (landing.fh.co/terms; accessed September 4, 2026)
• FuturHealth intake verification attempt (September 4, 2026)
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com; accessed September 9, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.